School of Pharmacy

Shelly Gray

Shirley & Herb Bridge Endowed Professor, School of Pharmacy Director, Plein Center for Geriatric Pharmacy Research, Education and Outreach

CHOICE Faculty, Department of Pharmacy, Institute for Innovative Pharmacy Practice, Pharmacy Faculty, Plein Center in Geriatrics Faculty, School Faculty

Telephone: (206) 616-5061

Email: slgray@uw.edu

Office Location: H361A Health Sciences Building Box 357630 1959 NE Pacific St Seattle WA 98195

Website: My Bibliography

Expertise: Central Nervous System, Claims Data, Deprescribing, Geriatrics, Health Outcomes, Medication Safety, Pharmacoepidemiology, Pharmacoepidemiology of Alzheimer’s disease and related dementias

Education

  • PharmD, University of Michigan
  • MS in Epidemiology, University of Washington

Courses Taught

  • PHARM 562: Pharmacotherapeutics V
  • PHARM 550: Seminar in Geriatrics

Research Interests

  • Medication safety in older adults
  • Deprescribing
  • Medication use and risk for falls, fractures, dementia

Biography

Dr. Gray has been a faculty member in the UW Department of Pharmacy since 1992. She is an investigator on numerous federally funded research grants and is author of more than sixty peer-reviewed publications. Earlier in her career, she received an American Association of Colleges of Pharmacy New Investigator Award and a Career Development Award from the National Institute on Aging. She serves on the editorial board for the “Annals of Pharmacotherapy”, “Journal of the American Geriatrics Society” and “Research in Gerontological Nursing”.

Gray has served as a consultant pharmacist for Providence Elderplace. Previously, she completed a two-year fellowship in geriatrics at the University of North Carolina at Chapel Hill and a clinical pharmacy residency at Thomas Jefferson University Hospital in Philadelphia. She has served on various committees of pharmacy and geriatric professional organizations.

Selected Publications

  • Gray SL, Anderson ML, Dublin S, et al. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Intern Med. 2015:2175(3):401-7.
  • Gray SL, Dublin S, Yu O, Walker R, Anderson M, Crane P, Larson E. Benzodiazepine use and risk of incident dementia or cognitive decline. BMJ. 2016;352:i90.
  • Gray SL, Walker RL, Dublin S, Yu O, Bowles EJ, Anderson ML, Crane PK, Larson EB. Proton pump inhibitor use and dementia risk. J Am Geriatr Soc. 2018;66(2):247-253.
  • Gray SL, Anderson ML, Hanlon JT, Dublin S, Walker R, Hubbard, RA, Yu O, Montine T, Sonnen J, Keene CD, Crane PK, Larson EB. Exposure to strong anticholinergic medications and dementia-related neuropathology in a community-based autopsy cohort. J Alzheimers Dis 2018;65(2):607-616.